AKT1 and small cell lung carcinoma: Further, in the drug-resistant cell lines derived from small cell lung cancer (SCLC) and lung adenocarcinoma, the CNTN1 and p-AKT levels were increased upon N-cadherin and vimentin upregulation and E-cadherin downregulation.